Bio Protech바이오프로테크
199290 · KONEX · ₩199290 · 바이오프로테크
- Market cap
- ₩7B
- Enterprise value
- —
- P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- ROE
- —
- Net margin
- —
Financial statements not available yet. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−39.4% from the high
₩279Today: ₩400 – ₩400₩660
Returns
- 1W+0.8%
- 1M0.0%
- 3M+2.6%
- 6M−8.0%
- YTD−19.8%
- 1Y−20.0%
- Volume today
- 1
- 0.0× the 20-day average
- Traded today
- ₩400
- Listed shares
- 17,533,127
- EPS (12 months)
- —
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 26 of 100 (50 is a normal day for this stock).
- MomentumFlat0% over the last month; the price is above its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Bio Protech stock overview
Bio Protech (바이오프로테크, KRX: 199290) is listed on KONEX, in the Medical & precision devices sector. The company operates in the biosensor segment of the electronic medical device consumables market, developing medical biosensor products based on its proprietary technology. Its shares closed at ₩400 on Oct 27, 2026, up 3.90% on the day, giving it a market value of ₩7B.
Key facts
- Market cap
- ₩7B
- Sector
- Medical & precision devices
- Latest price change
- +3.90%
- As of
- Oct 27, 2026
- Main business
- The company operates in the biosensor segment of the electronic medical device consumables market, developing medical biosensor products based on its proprietary technology.
Quick answers about Bio Protech
- What does Bio Protech do?
- The company operates in the biosensor segment of the electronic medical device consumables market, developing medical biosensor products based on its proprietary technology. Its business falls within the surgical and therapeutic devices and diagnostic and measurement devices categories of medical equipment, and it is pursuing research and development for new medical biosensor products.
- What is the market cap of Bio Protech?
- The market capitalisation of Bio Protech was ₩7B at the close on Oct 27, 2026.
- Who are the largest shareholders of Bio Protech?
- According to the latest official filings, the largest reported holders are Park Ik-ro (9.10%, as of Jun 5, 2026); Interbest (3.84%, as of Oct 2, 2026).
- When is the next earnings report from Bio Protech?
- Korean companies rarely announce results dates in advance. Based on when Bio Protech filed the same report in past years, its next annual results is expected between Mar 21, 2027 and Apr 1, 2027.
Company profile
The company operates in the biosensor segment of the electronic medical device consumables market, developing medical biosensor products based on its proprietary technology. Its business falls within the surgical and therapeutic devices and diagnostic and measurement devices categories of medical equipment, and it is pursuing research and development for new medical biosensor products.
Written by AI from the company's latest annual report.
- Korean name
- 바이오프로테크
- Themes
- Medical devices
- CEO
- 박익로,김병전 (공동대표이사)
- Founded
- May 2000
- Listed
- Dec 2016
- Listed shares
- 17,533,127
- Fiscal year ends
- Month 12
- Website
- www.protechsite.com
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- Investor relations (IR) eventOct 6, 2026
- 5%+ holding reportOct 2, 2026
- Exercise of Conversion Rights of Convertible SharesSep 30, 2026
- Investor relations (IR) eventSep 17, 2026
- Exercise of Conversion Rights of Convertible SharesJul 30, 2026
Titles in Korean until English translations are added.
Also known as: Bio Protech / 바이오프로테크 / 199290 / KRX:199290
Source: KRX statistical information